This page contains a Flash digital edition of a book.

7. Guckenberger M, Sweeney RA, Wilbert J, et al., Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography, Int J Radiat Oncol Biol Phys, 2008;71(1): 297–304.

8. Meyer J, Wilbert J, Baier K, et al., Positioning accuracy of cone- beam computed tomography in combination with a HexaPOD robot treatment table, Int J Radiat Oncol Biol Phys, 2007;67(4):1220–8.

9. Wilbert J, Baier K, Richter A, et al., Influence of continuous table motion on patient breathing patterns, Int J Radiat Oncol Biol Phys, 2010;77(2):622–9.

10. Thilmann C, Nill S, Tucking T, Hoss A, et al., Correction of patient positioning errors based on in-line cone beam CTs: clinical implementation and first experiences, Radiat Oncol, 2006;1:16.

11. de Crevoisier R, Tucker SL, Dong L, et al., Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy, Int J Radiat Oncol Biol Phys, 2005;62(4):965–73.

12. Heemsbergen WD, Hoogeman MS, Witte MG, et al., Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy, Int J Radiat Oncol Biol Phys, 2007;67(5):1418–24.

13. Zietman AL, DeSilvio ML, Slater JD, et al., Comparison of conventional-dose versus high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomised controlled trial, JAMA, 2005;294(10):1233–9.

14. Dearnaley DP, Sydes MR, Graham JD, et al., Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial, Lancet (Oncol), 2007;8(6):475–87.

15. Kuban DA, Tucker SL, Dong L, et al., Long-term results of the MD Anderson randomised dose-escalation trial for prostate cancer, Int J Radiat Oncol Biol Phys, 2008;70(1):67–74.

16. Al-Mamgani A, van Putten WL, Heemsbergen WD, et al., Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, 2008;72(4):980–8.

17. Fiorino C, Valdagni R, Rancati T, Sanguineti G, Dose-volume effects for normal tissues in external radiotherapy: pelvis, Radiother Oncol, 2009;93(2):153–67.

18. Wong JR, Gao Z, Merrick S, et al., Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images, Int J Radiat Oncol Biol Phys, 2009;75(1):49–55.

19. Stroup SP, Cullen J, Auge BK, et al., Effect of obesity on prostate- specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and

Oncology (RTOG-ASTRO) Phoenix consensus definition, Cancer, 2007;110(5):1003–9.

20. Strom SS, Kamat AM, Gruschkus SK, et al., Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer, Cancer, 2006;107(3):631–9.

21. Johansen J, Bertelsen A, Hansen CR, et al., Set-up errors in patients undergoing image guided radiation treatment. Relationship to body mass index and weight loss, Acta Oncol, 2008;47(7):1454–8.

22. Zelefsky MJ, Crean D, Mageras GS, et al, Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy, Radiother Oncol, 1999;50(2):225–34.

23. McGrath S, Kestin L, Dilworth J, et al., Adaptive image guided radiotherapy (IGRT) eliminates the risk of geometric miss due to rectal distention in prostate cancer treatment planning: biochemical and clinical evidence of efficacy, Int J Radiation Oncol Biol Phys, 2008;72(Suppl. 1):S324–5.

24. Bohrer M, Schroder P, Welzel G, et al., Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer, Strahlenther Onkol, 2008;184(12):674–8.

25. Chung HT, Xia P, Chan LW, et al., Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high- risk prostate cancer? Comparison between IG-IMRT and IMRT, Int J Radiat Oncol Biol Phys, 2009;73(1):53–60.

26. Guckenberger M, Ok S, Polat B, et al., Toxicity after intensity- modulated, image-guided radiotherapy for prostate cancer, Strahlenther Onkol, 2010;186(10):535–43.

27. Rowell NP, Williams CJ, Radical radiotherapy for stage I/II non- small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable), Cochrane Database Syst Rev, 2001(1):CD002935.

28. Yan TD, Black D, Bannon PG, McCaughan BC, Systematic review and meta-analysis of randomised and nonrandomised trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer, J Clin Oncol, 2009,27(15):2553–62.

29. Brenner DJ, Dose, volume, and tumour-control predictions in radiotherapy, Int J Radiat Oncol Biol Phys, 1993;26(1):171–9.

30. Furuse K, Fukuoka M, Kawahara M, et al., Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer, J Clin Oncol, 1999;17(9):2692–9.

31. Zatloukal P, Petruzelka L, Zemanova M, et al., Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomised study,

Lung Cancer, 2004;46(1):87–98.

32. Fournel P, Robinet G, Thomas P, et al., Randomised phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique- Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study, J Clin Oncol, 2005;23(25):5910–7.

33. Auperin A, Le Pechoux C, Rolland E, et al., Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer, J Clin Oncol, 2010;28(13):2181–90.

34. Willner J, Baier K, Caragiani E, et al., Dose, volume, and tumour control prediction in primary radiotherapy of non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 2002;52(2):382–9.

35. Guckenberger M, Wulf J, Mueller G, et al., Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumours: relevance of 4D dose calculation, Int J Radiat Oncol Biol Phys, 2009;74(1):47–54.

36. Kong FM, Ten Haken RK, Schipper MJ, et al., High-dose radiation improved local tumour control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study, Int J Radiat Oncol Biol Phys, 2005;63(2):324–33.

37. Grills IS, Hope AJ, Guckenberger M, et al., A multinational pooled analysis of 434 cases of stage I non-small cell lung cancer (NSCLC) treated with volumetrically image-guided (VIGRT) stereotactic lung radiotherapy (SBRT): Results from the Elekta Collaborative Lung Research Group, J Clin Oncol (Meeting Abstracts), 2010;28(Suppl. 15):7015.

38. Onishi H, Shirato H, Nagata Y, et al., Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?, Int J Radiat Oncol Biol Phys, 2010; (Epub ahead of print).

39. Liao ZX, Komaki RR, Thames HD Jr, et al., Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy, Int J Radiat Oncol Biol Phys, 2010;76(3):775–81.

40. Breneman JC, Steinmetz R, Smith A, et al., Frameless image- guided intracranial stereotactic radiosurgery: clinical outcomes for brain metastases, Int J Radiat Oncol Biol Phys, 2009;74(3):702–6.

41. Den RB, Doemer A, Kubicek G, et al., Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study, Int J Radiat Oncol Biol Phys, 2010;76(5):1353–9.

42. Rasmussen KH, Hardcastle N, Howard SP, Tome WA, Reirradiation of glioblastoma through the use of a reduced dose rate on a tomotherapy unit, Technol Cancer Res Treat, 2010;9(4):399–406.



Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68